Pinsent Masons advises Tan Chong on its tender offer to purchase shares in Zero Co. Ltd

07 Jul 2014 | 10:58 am |

International law firm Pinsent Masons has advised Tan Chong International Limited (“Tan Chong”), a Hong Kong Main Board listed company, on its tender offer to purchase an approximate 28% interest in Zero Co. Ltd (“Zero”), a Tokyo Stock Exchange listed company, for approximately HK$305 million (equivalent to approximately £23 million). Such interests acquired together with interests previously acquired by Tan Chong gives Tan Chong an aggregate current holding of approximately 51% interests in Zero.

The acquisition constituted a Major Transaction for Tan Chong under the Hong Kong Listing Rules. Pinsent Masons advised Tan Chong on the Hong Kong legal and regulatory aspects of the transaction.

Both Tan Chong and Zero are engaged in the automobile-related business. Tan Chong, through the tender offer, is expected to further expand its business in the ASEAN region through the establishment of a closer capital and business alliance with Zero.

The Pinsent Masons Team advising on the deal was led by Corporate Partner Kenneth Chong, assisted by Senior Associate Denise Chan and Trainee Solicitor Kris Cheung in the Hong Kong office.

Latest press releases

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons secures 11th place in Financial Times Diversity Leaders 2021 Report

Multinational law firm Pinsent Masons has been named as a top 20 Diversity Leader by the Financial Times, ranked 11th in its Diversity Leaders 2021 report.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ

Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts